CN112056405A - 健康养身饮料 - Google Patents
健康养身饮料 Download PDFInfo
- Publication number
- CN112056405A CN112056405A CN202010815843.2A CN202010815843A CN112056405A CN 112056405 A CN112056405 A CN 112056405A CN 202010815843 A CN202010815843 A CN 202010815843A CN 112056405 A CN112056405 A CN 112056405A
- Authority
- CN
- China
- Prior art keywords
- parts
- sugar
- black
- red dates
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 235000007215 black sesame Nutrition 0.000 claims abstract description 26
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 21
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 21
- 235000021279 black bean Nutrition 0.000 claims abstract description 21
- 235000000346 sugar Nutrition 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 241000218231 Moraceae Species 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000016709 nutrition Nutrition 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 5
- 240000000249 Morus alba Species 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 235000021552 granulated sugar Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000010411 cooking Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 36
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 13
- 239000011575 calcium Substances 0.000 abstract description 13
- 229910052791 calcium Inorganic materials 0.000 abstract description 13
- 230000032683 aging Effects 0.000 abstract description 10
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 9
- 210000004556 brain Anatomy 0.000 abstract description 7
- 208000001132 Osteoporosis Diseases 0.000 abstract description 6
- 230000004438 eyesight Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 235000001465 calcium Nutrition 0.000 description 11
- 210000004209 hair Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000004641 brain development Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000166550 Strophanthus gratus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 150000008209 arabinosides Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 229960003343 ouabain Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
发明涉及健康养身饮料，包括营养份和液体份；按重量份算，所述营养份包括，红枣8‑14份、黑芝麻2‑8份、黑豆6‑12份、桑葚4‑8份、糖0.8‑2份；所述液体份为水，份量的选择为满足整个饮料达到粘稠状。本发明达到的有益效果是：以黑芝麻为主料，其含钙量非常高，再以红枣为次料，并黑豆和桑葚为辅料，各组分结合后主要对预防骨质疏松有良好的效果；并且还兼备能够养身、调理、明目、抗氧化、补钙、补脑、补肾、抗衰老、抗结石、提高抵抗力、增强记忆等作用。
Description
技术领域
本发明涉及饮品技术领域，特别是健康养身饮料。
背景技术
目前，虽然人们生活越来越好，但健康却并不是特别理想。例如工作量大，需要经常加班，工作压力大；经常面对电脑，易衰老；饮食大鱼大肉，蔬菜食用少，维生素摄取量低，人体激素分泌失衡……
为此申请人研发一种健康养身饮料，适用于学生、中老年，以及工作压力大、经常用脑等人群，也适用于健康人群，特别是对于骨质疏松的人群而言，还具有养身、调理、明目、抗氧化、补钙、补脑、补肾、抗衰老、抗结石、提高抵抗力、增强记忆等功效，还具有除胃热痹、下淤等作用。
发明内容
本发明的目的在于克服现有技术的缺点，提供能够养身、调理、明目、抗氧化、补钙、补脑、补肾、抗衰老、抗结石、提高抵抗力、增强记忆的健康养身饮料。
本发明的目的通过以下技术方案来实现：健康养身饮料，包括营养份和液体份；
按重量份算，所述营养份，包括：
红枣 8-14份，
黑芝麻 2-8份，
黑豆 6-12份，
桑葚 4-8份，
糖 0.8-2份
所述液体份为水。
优选地，所述的糖为白砂糖。
优选地，所述的营养份中，红枣为10份，黑芝麻为5份，黑豆为10份，桑葚为6份，糖为1.5份。
优选地，所述的液体份中，水的份量为让整个饮料达到粘稠状为止。
在饮料制备时，红枣、黑芝麻、黑豆、桑葚先经水磨研碎后，再进行过滤，最后高温蒸煮；蒸煮过程中整个饮料达到粘稠状为止。
值得注意的是，糖在制备过程中可选择性地添加至任意步骤中。
本发明具有以下优点：本方案，以黑芝麻为主料，其含钙量非常高，再以红枣为次料，并黑豆和桑葚为辅料，各组分结合后主要对预防骨质疏松有良好的效果；并且还兼备能够养身、调理、明目、抗氧化、补钙、补脑、补肾、抗衰老、抗结石、提高抵抗力、增强记忆等作用。
具体实施方式
下面对本发明做进一步的描述，但本发明的保护范围不局限于以下所述。
健康养身饮料，包括营养份和液体份。
具体地，营养份，按重量份算包括：红枣8-14份、黑芝麻2-8份、黑豆6-12份、桑葚4-8份、糖0.8-2份；液体份的份量选择为满足整个饮料呈粘稠状为止。
本方案中，优选地，糖为白砂糖；液体份为水。
优选地，营养份中，红枣优选10份，黑芝麻优选5份，黑豆优选10份，桑葚优选6份，糖优选1.5份。
本方案在制备时，红枣、黑芝麻、黑豆、桑葚先经水磨研碎后，再进行过滤，最后高温蒸煮；蒸煮过程中整个饮料达到粘稠状为止。
糖可以选择性地添加在制备过程中的任意步骤中。
在红枣中，富含多种维生素和有益物质，如蛋白质、脂肪、氨基酸、维生素A、维生素C、维生素B1、维生素B2、维生素P以及其他微量元素等；还含有葡萄糖，阿拉伯聚素树脂，黏液质、香豆素、儿茶酚鞣质挥发油、类衍生物等。有益补血气，有养颜、美容、抗衰老等功效。
具体地，红枣所含的糖类、蛋白质、脂肪，是保护肝脏的营养元素，能促进肝脏合成蛋白，增加血清红蛋白与蛋白的含量，有预防输血反应、降低血清谷雨转氨酶水平的作用。
红枣中大量的维生素B可以促进皮下血液循环，使皮肤和毛发光润，消除面部皱纹。红枣含有的维生素C含量几乎比所有水果的含量都高，作为一种活性很强的还原抗氧化物质，参与体内的生理氧气还原过程，防止黑色素在体内沉积，预防色斑产生；并且将体内多余的胆固醇转变成胆汁酸，减少结石形成的概率。红枣中的维生素P具有维持毛血细管通透性，从而改善微循环，以达到预防动脉硬化的作用；其含有芦丁，可以使血管年轻化，达到降低血压的目的，对高血压有预治功效。
红枣中还富含铁和钙，对预防骨质疏松有良好作用，是女性更年期及中老年的食疗佳品。铁元素是合成血红的元素，因此红枣可以补气生血，适于体质虚弱、贫血者以及女性月经后食用。并且铁、钙元素以及还蕴含的丰富的黄酮类物质，能够疏肝解郁、养血安神，有明显的镇静催眠和降压作用，适于调理焦躁不安、心神不宁或睡眠不好的人食用。
红枣中富含的环磷酸腺苷是人体能量代谢的必需物质，能消除疲劳、扩张血管、改善心肌营养、增加肌力、有防治心血管病的作用。
红枣中所含的皂类位置有调节人体代谢，增加免疫力，减低血糖和胆固醇含量等作用。
红枣具有排毒养肝，减轻毒性位置对肝脏的损害作用，适用肝脏功能较差的人群食用；当每天泡红枣坚持一星期后，身体内的血清蛋白有明显的增加，起到排毒的功效。
故红枣中含有的各类营养物质，具有补中益气、养血安神的作用，适用于脾虚食少、乏力便秘、脏躁失眠的人群食用。
黑芝麻中含有人体所需的多种微量元素和矿元素，维生素A、维生素E、蛋白质、脂肪、糖类、芝麻酚、卯磷脂、铁、钙、铬等，其含有的脂肪酸有提高大脑发育和改善记忆力的作用，特别是孕妇食用黑芝麻后对胎儿的大脑发育非常重要。
黑芝麻能有效促进头发黑色素合成，使白发恢复色泽，同时能环缓解肾虚导致的头发问题。
黑芝麻中含有维生素E，其作用在红枣中已经阐明。
黑芝麻中所含氨基酸、维生素丰富，能促进新城代谢，提高人体免疫力。还具有降糖降胆固醇的功效，能调节肝糖原和肌糖原的水平，有利降低血液中胆固醇水平，能有效预防动脉硬化。
黑芝麻中锁含的不饱和氨基酸（如油酸、亚油酸等）含量丰富，能促进大脑发育，提高智力、记忆力，适用于经常用脑人群。
黑芝麻中的油脂和纤维素能润滑肠道，帮助失误消化和通便排毒，减少身体的毒素存积。
黑芝麻中所含的卯磷脂能促进胆汁合成，有效的降低胆固醇，能预防结石的型材。黑芝麻具有补肝、补肾、润五脏、益气力、长肌肉、填脑髓、乌发等功效，可用于治疗肝肾精血不足所致的眩晕、须发早白、脱发、腰膝酸软、四肢乏力、五脏虚损、皮燥发干、肠燥便秘等症。
黑芝麻中富含的铁元素能改善贫血，铁元素具体作用在红枣中已经阐明。并且黑芝麻中钙含量高达0.8%，远高于牛奶和鸡蛋，能很好地促进骨骼发育和预防骨质疏松等问题。
黑豆具有清热解毒、补血、养肾的功效，具有抗衰防老等作用，还能养气、滋补、明目。既有祛风、防热、活血以及无法等功效，还有除胃中热痹下淤、散五脏结积的作用。能改善肠胃，排出毒素，改善菌群环境。
具体地，黑豆中所含的肥草甙，有减少体内胆固醇的作用，能有效预防中老年动脉硬化和血管疾病。黑豆中含有天然的黑色素，对肾虚、体弱、腰膝酸软、风湿关节等有一定的帮助。
黑豆中含有维生素E，其作用在红枣中已经阐明。
黑豆中还含有微量元素，如锌、铜、镁、钼、硒、氟等含量都很高，这些元素对延缓人体衰老、降低血糖粘度起到重要作用。
黑豆中还含有花青素，是良好的抗氧化剂，能消除体内的自由基，尤其是在胃中酸性环境下，抗氧化效果非常独特。黑豆还含有非常高的黄酮，是一种天然的养颜美容养生品。
桑葚含有特别丰富的脂肪酸、铁元素、维生素C，还含有活性蛋白、氨基酸、胡萝卜素、矿物质、葡萄糖、蔗糖、果糖、苹果酸、鞣质、钙、维生素B1、维生素B2、尼克酸等成分，其营养是苹果的5-6倍，是葡萄的4倍。
桑葚有生津止渴、润燥润肠等作用；适用于肾虚精亏导致的腰膝酸软、夜尿频多、潮热盗汗、耳鸣耳聋、五脏烦热、牙齿松动、足跟作痛、关节不利，肢体麻木、以及阳痿、早泄、性欲减退等。
桑葚有生发、乌发的作用，能补肾益精，适用于未老先衰、须发早白、头发脱落、眉毛稀疏和斑秃、头发枯萎的病人。
桑葚具有的补血功效，可用于治疗头晕目眩、视物昏花、面色苍白、爪甲无华，对于对月经量少或者卵巢早衰、乳汁不足的女性也有很好的治疗作用。还可以养颜防衰，适用于眼圈发黑、皮肤干燥、皮肤瘙痒、皱纹较多、色斑较多、形体消瘦等人群，对闭经、白癜风等病人都有一定效果。
桑葚还具有宁心安神等功效，特别是对于精血不足、心悸健忘、失眠多梦、早醒易惊、急躁易怒等情况。还兼备通便润肠，特别是精血不足所导致的大便干洁，数日不解导致的腹胀、腹满等习惯性便秘也有良好的效果。
桑葚中含有的大量维生素C和花青素，其抗氧化作用，可以减轻自由基对皮肤细胞的损害，起到美白减皱、延缓衰老的功效。
而鞣酸、脂肪酸、苹果酸等营养物质，能帮助脂肪、蛋白质及淀粉的消化，故有健脾胃助消化之功效。
白砂糖，是由一些含糖植物和蔗糖汁提炼而成，含量在99%以上，以葡萄糖和果糖为主，此外还含有多种氨基酸、钙、磷、铁和维生素B2等成分。
白砂糖具有润肺生津、补中益气、清热燥湿、化痰止咳、解毒醒酒、降浊怡神等功效，可用于治疗肺燥咳嗽、口干燥渴、中虚脘痛、脾虚泄泻以及盐卤中毒、阴囊湿疹等病症。
白糖的结晶颗粒大小不同，而白糖的结晶颗粒小含水分较多，它都是纯水碳水化合物，只供热能，但具有润肺生津和中益肺、舒缓肝气的功效。
本方案主要以红枣、黑芝麻、黑豆、桑葚、白砂糖为主要原料，均为天然组分，通过各组分之间的相互促进作用，为绿色健康养身饮料，从而补足人体对各营养物质的摄入量，最终提高人的体质。
本方案中，以黑芝麻为主料，其含钙量非常高，再以红枣为次料，并黑豆和桑葚为辅料，各组分结合后主要对预防骨质疏松有良好的效果。
上述实施例仅表达了较为优选的实施方式，其描述较为具体和详细，但并不能因此而理解为对本发明专利范围的限制。应当指出的是，对本领域的普通技术人员来说，在不脱离本发明构思的前提下，还可以做出若干变形和改进，这些都属于本发明的保护范围。
Claims (6)
1.健康养身饮料，其特征在于：包括营养份和液体份；
按重量份算，所述营养份，包括：
红枣 8-14份，
黑芝麻 2-8份，
黑豆 6-12份，
桑葚 4-8份，
糖 0.8-2份
所述液体份为水。
2.根据权利要求1所述的健康养身饮料，其特征在于：所述的糖为白砂糖。
3.根据权利要求2所述的健康养身饮料，其特征在于：所述的营养份中，红枣为10份，黑芝麻为5份，黑豆为10份，桑葚为6份，糖为1.5份。
4.根据权利要求3所述的健康养身饮料，其特征在于：所述的液体份中，水的份量为让整个饮料达到粘稠状为止。
5.根据权利要求1~4任意一项所述的健康养身饮料，其特征在于：所述的红枣、黑芝麻、黑豆、桑葚先经水磨研碎后，再进行过滤，最后高温蒸煮；蒸煮过程中整个饮料达到粘稠状为止。
6.根据权利要求5所述的健康养身饮料，其特征在于：所述的糖在制备过程中可选择性地添加至任意步骤中。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010815843.2A CN112056405A (zh) | 2020-08-14 | 2020-08-14 | 健康养身饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010815843.2A CN112056405A (zh) | 2020-08-14 | 2020-08-14 | 健康养身饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112056405A true CN112056405A (zh) | 2020-12-11 |
Family
ID=73661523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010815843.2A Pending CN112056405A (zh) | 2020-08-14 | 2020-08-14 | 健康养身饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112056405A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113749152A (zh) * | 2021-09-13 | 2021-12-07 | 李友贵 | 一种健康养生强身饮品及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070806A (zh) * | 1992-07-07 | 1993-04-14 | 曹光荣 | 一种黑色保健食品冲剂的生产方法 |
| CN103271200A (zh) * | 2013-06-06 | 2013-09-04 | 卢勇 | 三黑咖啡 |
| CN104336675A (zh) * | 2014-10-27 | 2015-02-11 | 哈尔滨市呼兰区天成新农村家庭农场 | 黑芝麻枸杞营养粥及制作方法 |
| CN104814428A (zh) * | 2015-04-09 | 2015-08-05 | 范振之 | 一种用于治疗脱发白发的营养组合物 |
| CN111149984A (zh) * | 2018-11-07 | 2020-05-15 | 获嘉天众生物技术有限公司 | 一种发酵型冲调方便食品的制备方法 |
-
2020
- 2020-08-14 CN CN202010815843.2A patent/CN112056405A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070806A (zh) * | 1992-07-07 | 1993-04-14 | 曹光荣 | 一种黑色保健食品冲剂的生产方法 |
| CN103271200A (zh) * | 2013-06-06 | 2013-09-04 | 卢勇 | 三黑咖啡 |
| CN104336675A (zh) * | 2014-10-27 | 2015-02-11 | 哈尔滨市呼兰区天成新农村家庭农场 | 黑芝麻枸杞营养粥及制作方法 |
| CN104814428A (zh) * | 2015-04-09 | 2015-08-05 | 范振之 | 一种用于治疗脱发白发的营养组合物 |
| CN111149984A (zh) * | 2018-11-07 | 2020-05-15 | 获嘉天众生物技术有限公司 | 一种发酵型冲调方便食品的制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 李小山 等: "《本草纲目药膳大全集》", 31 December 2011, 湖南美术出版社 * |
| 龙其德: "阳强不射精症", 《湖南中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113749152A (zh) * | 2021-09-13 | 2021-12-07 | 李友贵 | 一种健康养生强身饮品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
| CN105211863A (zh) | 一种制作姜枣淮山酵素的组合物及其姜枣淮山酵素 | |
| CN101416735B (zh) | 一种营养滋补蜜枣罐头及其制备方法 | |
| CN109198550A (zh) | 一种燕窝和花胶组合的食物及其制备方法 | |
| CN110037113A (zh) | 一种女士瘦身养颜奶粉 | |
| CN104799358A (zh) | 一种风味花生酱的生产方法 | |
| CN109247571A (zh) | 一种抗衰防老养生保健食品及其制备方法 | |
| CN104323391B (zh) | 一种植物保健固体饮料及其制备方法 | |
| CN113598344A (zh) | 一种五黑醋膏丸及其制备方法 | |
| CN107549619A (zh) | 一种促进头发变黑的膳食组合物 | |
| CN112056405A (zh) | 健康养身饮料 | |
| CN109123621A (zh) | 一种可调节机体免疫功能抑制血糖升高的保健食品 | |
| CN104799370B (zh) | 一种保健饮料及其制备方法 | |
| CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
| CN102526537A (zh) | 一种治疗高血糖的药物组合物 | |
| CN106135525A (zh) | 一种袋泡核桃红茶及其制备方法 | |
| CN112931742A (zh) | 一种美白嫩肤抗衰老的固体饮料及其制备方法 | |
| CN112587612A (zh) | 一种牡蛎鹿鞭膏及其制备方法 | |
| CN112273653A (zh) | 一种双向改善胃肠道功能、减肥美容谷物果蔬组合物 | |
| KR20090038595A (ko) | 보양식 순대소 조성물 및 그를 이용한 순대 제조방법 | |
| CN108552528A (zh) | 一种保护血管及增强免疫力猕猴桃酵素及其生产方法 | |
| CN109892585A (zh) | 一种养生水果制作方法 | |
| CN101167570A (zh) | 葛片槟榔 | |
| CN112592782A (zh) | 健康养生红酒 | |
| CN105767858A (zh) | 一种改善睡眠质量的功能性营养食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201211 |